ADMA Biologics, Inc.ADMANASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank71
3Y CAGR+21.7%
5Y CAGR+36.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+21.7%/yr
vs -1.9%/yr prior
5Y CAGR
+36.8%/yr
Recent deceleration
Acceleration
+23.6pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
4.8x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.11 | -20.5% |
| 2024 | 11.45 | +53.0% |
| 2023 | 7.49 | +48.2% |
| 2022 | 5.05 | +262.4% |
| 2021 | 1.39 | -26.8% |
| 2020 | 1.90 | -77.1% |
| 2019 | 8.30 | +51.9% |
| 2018 | 5.46 | +199.8% |
| 2017 | 1.82 | +113.1% |
| 2016 | -13.96 | - |